Analytical Quality by Design in Stress Testing or Stability - Indicating Method
Analytical methods are required to be developed at different stages of the pharmaceutical product life cycle. The concept of QbD can be extended to analytical method development known as analytical quality by design (AQbD). Quality by design is a systematic approach to development that begins with p...
Saved in:
Published in | Asian Journal of Pharmaceutical Analysis Vol. 11; no. 2; pp. 170 - 178 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Raipur
Athena Information Solutions Pvt. Ltd
01.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Analytical methods are required to be developed at different stages of the pharmaceutical product life cycle. The concept of QbD can be extended to analytical method development known as analytical quality by design (AQbD). Quality by design is a systematic approach to development that begins with predefined objects and emphasizes product and process understanding and helps in the systematic approach to drug development. The concepts described in ICH Q8- Q11, commonly referred to as quality by design (QbD), have also been applied to the development of analytical methods. The benefits of applying the QbD principle to analytical methods include identifying and minimizing sources of variability that may lead to poor method robustness and ensuring that the method meets its intended performance requirements throughout the product and method lifecycle. Stress testing is a very important tool in pharmaceutical research and development to predict long-term stability. Stress studies should be performed in stability-indicating method development to understand drug behavior but also can be performed with method validation for regulatory filling predict stability and measure impurities. For determination of degradation pathways and structural elucidation of degradation produced, these stress testing are helpful. It is also used to select the storage condition and improve the manufacturing process of formulations. |
---|---|
AbstractList | Analytical methods are required to be developed at different stages of the pharmaceutical product life cycle. The concept of QbD can be extended to analytical method development known as analytical quality by design (AQbD). Quality by design is a systematic approach to development that begins with predefined objects and emphasizes product and process understanding and helps in the systematic approach to drug development. The concepts described in ICH Q8- Q11, commonly referred to as quality by design (QbD), have also been applied to the development of analytical methods. The benefits of applying the QbD principle to analytical methods include identifying and minimizing sources of variability that may lead to poor method robustness and ensuring that the method meets its intended performance requirements throughout the product and method lifecycle. Stress testing is a very important tool in pharmaceutical research and development to predict long-term stability. Stress studies should be performed in stability-indicating method development to understand drug behavior but also can be performed with method validation for regulatory filling predict stability and measure impurities. For determination of degradation pathways and structural elucidation of degradation produced, these stress testing are helpful. It is also used to select the storage condition and improve the manufacturing process of formulations. According to ICH Q8 guidelines, QbD can be defined as “A Systematic approach for development that begins with predefined objectives and emphasizes the product and process understanding as well as process control, based on sound science and quality risk management. [...]changes in method failure during movement are always high. [...]the performance variable is not fully explored and knowledge. [...]the below the comparison of traditional and AQbD approaches. PART-A framework for innovative pharmaceutical development, manufacturing, and quality assurance Sep 2004 USFDA Pharmaceutical cGMP for the 21st century-A risk-based approach: final report Sep 2004 EMA The European medicines agency road map to 2010: preparing the ground for the future March 2005 ICH Pharmaceutical development (Q8) Nov 2005 ICH Quality risk management (Q9) Nov 2005 ICH Pharmaceutical quality system (Q10) June 2008 ICH Pharmaceutical development (Q8(R2)) Aug 2009 WHO Quality risk management Aug 2010 EMA Road map to 2015 Dec 2010 USFDA Guidance for industry: process validation: general principles and practices Jan 2011 EMA-USFDA EMA-FDA pilot program for parallel assessment of quality by design applications March 2011 ICH ICH- An endorsed guide for ICH Q8/Q9/Q10 Implementation Dec 2011 EMA ICH Quality IWG points to consider for ICH Q8/Q9/Q10 Guidelines Feb 2012 EMA Guidelines on real-time release testing (formerly guideline on parametric release) March 2012 EMA Guideline on process validation (draft) March 2012 USFDA Quality by design for ANDAs: an example for immediate- release dosage forms April 2012 ICH Development and manufacturing of drug substances (chemical entities and biotechnological/biological entities) (Q11) May 2012 EMA- US- FDA EMA- FDA pilot program for parallel assessment of quality-by-design application: lessons learned and QandA resulting from the first parallel assessment Aug 2013 EMA Guidelines on process validation for finished products – information and data to be provided in regulatory submission Feb 2014 1.4 Regulatory guidelines analytical QbD: Historically, designing or building the quality into products had been a necessity for complex manufacturing operations, like, aircraft manufacturing. |
Author | Vyas, Amitkumar J. Patel, Nilesh K. Shah, Sunny R. Patel, Ajay I. Visana, Nilam M. Patel, Ashok B. |
Author_xml | – sequence: 1 givenname: Amitkumar J. surname: Vyas fullname: Vyas, Amitkumar J. organization: 1Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India – sequence: 2 givenname: Nilam M. surname: Visana fullname: Visana, Nilam M. organization: Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India – sequence: 3 givenname: Ajay I. surname: Patel fullname: Patel, Ajay I. organization: Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India – sequence: 4 givenname: Ashok B. surname: Patel fullname: Patel, Ashok B. organization: Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India – sequence: 5 givenname: Nilesh K. surname: Patel fullname: Patel, Nilesh K. organization: Pharmaceutical Quality Assurance Department, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India – sequence: 6 givenname: Sunny R. surname: Shah fullname: Shah, Sunny R. organization: Pharmaceutical Department, B. K. Mody Government Pharmacy Collage, Rajkot, Gujarat, India |
BookMark | eNo9kN1KAzEQhYMoWGsfQQh4vTWZNOnuZal_hUoR63VIskmNrNmabC_27U23UhiY4cyZYea7QZehDRahO0qmHOaUPgAwWnAx51MgQKeEEKgu0OgsX55rMb9Gk5S8JjMhKKk4HaHNIqim77xRDX4_qMZ3PdY9frTJ7wL2AX900aaEtzZ1PuxwG7OitB-MBV6FOo8OnTfbfbX1Lbpyqkl28p_H6PP5abt8Ldabl9VysS4MBVEWtLa1YQqItkxYcCpHRUildA3KgTZQauZK45wBA7qytRasKksyYxV3JWdjdH_au4_t7yEfJ7_bQ8y_JAmcMz4j2Z1d_OQysU0pWif30f-o2EtK5IBPHtnIIyd5xCcHfOwPTOJkNw |
CitedBy_id | crossref_primary_10_3390_pharmaceutics15102371 crossref_primary_10_18596_jotcsa_1288000 crossref_primary_10_52711_0974_360X_2024_00153 crossref_primary_10_52711_0974_360X_2024_00263 crossref_primary_10_52711_2231_5675_2023_00019 crossref_primary_10_52711_2231_5691_2022_00048 crossref_primary_10_37285_ijpsn_2023_16_2_4 crossref_primary_10_37285_ijpsn_2023_16_4_4 crossref_primary_10_52711_0974_360X_2023_00847 crossref_primary_10_52711_0974_360X_2023_00647 crossref_primary_10_52711_0974_360X_2023_00942 crossref_primary_10_52711_0974_360X_2022_00697 crossref_primary_10_1002_masy_202300142 crossref_primary_10_52711_2231_5675_2023_00022 |
Cites_doi | 10.5958/2231-5675.2019.00021.8 10.1016/j.jpha.2013.09.003 10.4103/2230-973X.187350 10.21276/irjps.2020.7.2.4 10.2478/amma-2019-0010 10.15406/japlr.2016.03.00073 10.1155/2015/868727 10.5958/0974-360x.2017.00223.2 10.23880/oajpr-16000140 10.26717/BJSTR.2017.01.000484 10.5958/0974-360X.2017.00567.4 10.5958/2231-5675.2020.00029.0 10.7897/2230-8407.04517 10.5958/0975-4377.2019.00039.9 10.5958/2231-5659.2016.00007.2 10.5958/2231-5659.2017.00030.3 10.18231/2394-2797.2018.0001 10.1016/B978-0-12-375680-0.00003-6 10.5958/2231-5675.2016.00019.3 10.1201/9780849359194 |
ContentType | Journal Article |
Copyright | Copyright 2021 A & V Publication, distributed by Contify.com |
Copyright_xml | – notice: Copyright 2021 A & V Publication, distributed by Contify.com |
DBID | AAYXX CITATION 3V. 7X7 7XB 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S PQEST PQQKQ PQUKI PRINS |
DOI | 10.52711/2231-5675.2021.00029 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland AUTh Library subscriptions: ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Central (Alumni) |
DatabaseTitleList | CrossRef ProQuest One Academic Eastern Edition |
Database_xml | – sequence: 1 dbid: 7X7 name: Health & Medical Collection (Proquest) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2231-5675 |
EndPage | 178 |
ExternalDocumentID | 10_52711_2231_5675_2021_00029 |
GeographicLocations | United States--US India |
GeographicLocations_xml | – name: United States--US – name: India |
GroupedDBID | 7UP 7X7 8AO 8FI 8FJ AAYXX ABUWG ADBBV AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVXVI CCPQU CITATION FYUFA HMCUK PQQKQ UKHRP 3V. 7XB 8FK K9. PQEST PQUKI PRINS |
ID | FETCH-LOGICAL-c1268-1dedc3a20be36e2fa2fa9009abd2af2bc28b3f8cffc2c2b9edb6398804395f853 |
IEDL.DBID | BENPR |
ISSN | 2231-5667 |
IngestDate | Thu Oct 10 16:26:32 EDT 2024 Fri Aug 23 03:41:34 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1268-1dedc3a20be36e2fa2fa9009abd2af2bc28b3f8cffc2c2b9edb6398804395f853 |
PQID | 2553540988 |
PQPubID | 2044948 |
PageCount | 9 |
ParticipantIDs | proquest_journals_2553540988 crossref_primary_10_52711_2231_5675_2021_00029 |
PublicationCentury | 2000 |
PublicationDate | 20210601 |
PublicationDateYYYYMMDD | 2021-06-01 |
PublicationDate_xml | – month: 06 year: 2021 text: 20210601 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Raipur |
PublicationPlace_xml | – name: Raipur |
PublicationTitle | Asian Journal of Pharmaceutical Analysis |
PublicationYear | 2021 |
Publisher | Athena Information Solutions Pvt. Ltd |
Publisher_xml | – name: Athena Information Solutions Pvt. Ltd |
References | ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref0 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – ident: ref8 doi: 10.5958/2231-5675.2019.00021.8 – ident: ref39 – ident: ref3 – ident: ref26 doi: 10.1016/j.jpha.2013.09.003 – ident: ref7 – ident: ref17 doi: 10.4103/2230-973X.187350 – ident: ref0 doi: 10.21276/irjps.2020.7.2.4 – ident: ref29 – ident: ref37 doi: 10.2478/amma-2019-0010 – ident: ref24 – ident: ref34 doi: 10.15406/japlr.2016.03.00073 – ident: ref22 – ident: ref25 – ident: ref18 doi: 10.1155/2015/868727 – ident: ref27 – ident: ref5 doi: 10.5958/0974-360x.2017.00223.2 – ident: ref32 – ident: ref20 doi: 10.23880/oajpr-16000140 – ident: ref15 – ident: ref9 doi: 10.26717/BJSTR.2017.01.000484 – ident: ref11 doi: 10.5958/0974-360X.2017.00567.4 – ident: ref30 – ident: ref13 – ident: ref1 doi: 10.5958/2231-5675.2020.00029.0 – ident: ref36 – ident: ref2 – ident: ref12 doi: 10.1155/2015/868727 – ident: ref31 doi: 10.7897/2230-8407.04517 – ident: ref38 doi: 10.5958/0975-4377.2019.00039.9 – ident: ref14 doi: 10.5958/2231-5659.2016.00007.2 – ident: ref28 – ident: ref16 doi: 10.5958/2231-5659.2017.00030.3 – ident: ref21 – ident: ref4 doi: 10.18231/2394-2797.2018.0001 – ident: ref23 – ident: ref33 doi: 10.1016/B978-0-12-375680-0.00003-6 – ident: ref6 doi: 10.5958/2231-5675.2016.00019.3 – ident: ref19 doi: 10.1201/9780849359194 – ident: ref10 – ident: ref35 |
SSID | ssib046610951 ssib041264454 ssj0002964730 |
Score | 2.2009544 |
Snippet | Analytical methods are required to be developed at different stages of the pharmaceutical product life cycle. The concept of QbD can be extended to analytical... According to ICH Q8 guidelines, QbD can be defined as “A Systematic approach for development that begins with predefined objectives and emphasizes the product... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 170 |
SubjectTerms | 21st century Chromatography Drug dosages Manufacturing Methods Pharmaceutical industry Pharmaceuticals Pharmacy Principles Process controls Product development Product life cycle Quality control Reproducibility Variables |
Title | Analytical Quality by Design in Stress Testing or Stability - Indicating Method |
URI | https://www.proquest.com/docview/2553540988 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEG4ELl6MRo0okh68Fmj32ZPxAUET0Cgk3Jq-1nhZEPDAv3fa7YZwMdlTm91kv7bzfTNtZxC6K4BWlOKaKC4liUHwE27cugJyi4zJFcvdReHJNB3P49dFsggBt004VlnbRG-ozVK7GHkfpK8LUfA8v1_9EFc1yu2uhhIaDdRi4CmwJmo9DqfvH_WMiqnj-z1hxqnLLh72wZytdpuOmS9IAjRJCWibrLrmk7CM0n5ozBJwJBnt-RcOCezQfntSGp2ik6Am8UM1_GfoyJbn6M0nGvExalylyNhhtcPP_qwG_i7xp78fgmcuwUb5hZdraKnSde8wwS-l8XE86Jn48tIXaD4azp7GJNRNIBr-F5xCY42OJBsoG6WWFRIeDlpKKsNkwZRmuYqKXBeFZpopbo0CnQILGcRJUgB_X6JmuSztFcIDqVNJI02tBvAjDfqBy1hqZtNMSpq2Ua8GQ6yq9BgC3AqPnnDoCYeecOgJj14bdWrIRFgtG7Ef2-v_u2_QsftUdVSrg5rb9a-9BVGwVV3UyBZZN4z_HzcCsL8 |
link.rule.ids | 315,783,787,12070,21402,27938,27939,31733,33758,43324,43819 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NTwIxEG0UD3oxGjWiqD14LdDush8nY1QCCngQEm5Nv9Z4WRDwwL93plskXEz21M1usq_bea_T9g0h9wXQita5YTpXisUg-FlucVwBuUXWZlpkeFB4OEp6k_h12pmGhNsybKvcxEQfqO3MYI68BdIXUxR5lj3MvxlWjcLV1VBCY58coA8Xeuen0z86jTmy_ZYu4wS9xcMqGEZqXHJMfTkSIEnOQNmk1SGfjkg5b4XGtAPTSMGb_oFd-tqN3p6SuifkOGhJ-lh1_inZc-UZefc2Iz5DTSuDjDXVa_rsd2rQr5J--NMhdIz2GuUnnS2gpTLrXlNG-6X1WTy4M_TFpc_JpPsyfuqxUDWBGfhemBJaZ02kRFu7KHGiUHDloKSUtkIVQhuR6ajITFEYYYTOndWgUmAYgzTpFMDeF6RWzkp3SWhbmUTxyHBnAPrIgHrIVayMcEmqFE_qpLkBQ84rcwwJkwqPnkT0JKInET3p0auTxgYyGcbKUm579ur_23fksDceDuSgP3q7Jkf42mrTVoPUVosfdwPyYKVv_T_wC2s2sWM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analytical+Quality+by+Design+in+Stress+Testing+or+Stability+-+Indicating+Method&rft.jtitle=Asian+Journal+of+Pharmaceutical+Analysis&rft.au=Vya%2C+Amitkumar+J&rft.au=Visana%2C+Nilam+M&rft.au=Patel%2C+Ajay+I&rft.au=Patel%2C+Ashok+B&rft.date=2021-06-01&rft.pub=Athena+Information+Solutions+Pvt.+Ltd&rft.issn=2231-5667&rft.eissn=2231-5675&rft.volume=11&rft.issue=2&rft_id=info:doi/10.52711%2F2231-5675.2021.00029 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2231-5667&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2231-5667&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2231-5667&client=summon |